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Abstract
Patients with systemic lupus erythematosus (SLE) develop
multiple autoantibodies to self-antigens. Analysis of autoanti-
body systems in this and related autoimmune disorders can
provide information of etiologic and pathogenetic significance.
We report here a previously unrecognized autoantibody to the
90,000-D heat-shock protein, hsp90, a molecule thought to
have important functions in the cellular response to stress,
virus-induced transformation, steroid hormone receptor action,
and cellular activation. Autoantibodies to hsp90 were exclu-
sively of the IgG class, and were detected in - 50% of unse-
lected patients with SLE and 2/6 patients with idiopathic
polymyositis. Anti-hsp90 antibodies were not detected in sera
from 10 normal subjects, 10 patients with rheumatoid arthritis,
or 7 patients with scleroderma. The identity of this major in-
tracytoplasmic antigen was established by its specific removal
from nonionic detergent cell lysates following immunoabsorp-
tion with monospecific rabbit anti-hsp90, and by demonstra-
tion of increased synthesis following a 10-min 450C heat
shock. These data define the frequent occurrence of a novel
autoantibody to a major heat-shock protein in patients
with SLE.
Introduction
A central feature of systemic lupus erythematosus (SLE) is the
development of autoantibodies to multiple self-constituents.
Several autoantibodies in this disorder, i.e., those to double-
stranded DNA and to the nuclear antigen, Sm, are essentially
disease-specific (1), and their presence in patient serum is of
important diagnostic utility. Others, such as those directed to
surface membrane determinants on lymphocytes, contribute
substantially to the T cell depletion and immunoregulatory
dysfunction characteristic of patients with active SLE (re-
viewed in 2).
We report here a hitherto unrecognized IgG autoantibody
in - 50% of unselected patients with SLE to a 90-kD heat-
shock protein, hsp9O' (3, 4). The exact function(s) of heat-
shock proteins (5) is unknown, but recent evidence that hsp9O
forms stable complexes in the cells with certain virus-encoded
transforming proteins (6, 7), steroid receptors (8), and F-actin
(3, 4) raises the possibility that autoantibodies to this antigen
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1. Abbreviations used in this paper: hsp9O, 90-kD heat shock protein.
could exert important effects on the biology of the cell in this
disorder. In addition, because molecular mimicry (epitope ho-
mology) between microbial antigens and self-proteins may
underlie autoantibody formation in autoimmune and infec-
tious diseases (9, 10), etiologic information with respect to
putative viral "triggers" of SLE may derive from the present
observations as well.
Methods
Patients and serum. Venous blood was obtained from patients attend-
ing the University ofNorth Carolina Lupus Clinic who met the Ameri-
can Rheumatism Association revised criteria for classification as SLE
(11), and from 10 normal subjects. After separation from blood, serum
was aliquoted and stored at -70'C. Each serum aliquot was heated at
560C for 1 h immediately before use to inactivate C. For certain ex-
periments, serum was ultracentrifuged at 105,000 g for 2 h at 4VC to
remove Clq-binding immune complexes and IgG aggregates (12).
Lymphocytes. Normal human peripheral blood mononuclear cells
(PBMC) were separated from heparinized blood by flotation on LSM
(Litton Bionetics, Kensington, MD). To obtain activated T cells,
PBMC were cultured for three days in tissue culture flasks (Falcon
Labware, Div. Becton, Dickinson, and Co., Oxnard, CA) at a density
of 106/ml in RPMI 1640 medium containing phytohemagglutinin
(PHA; Burroughs Wellcome, Research Triangle Park, NC) at a final
concentration of 1 ug/ml, 2mM glutamine, antibiotics, and 10% FCS.
Cell lines (SB and HSB-2, provided by Dr. B. Haynes, Duke Univer-
sity, Durham, NC; Jurkat and HUT 78, provided by Dr. A. Altman,
Scripps Clinic and Research Foundation, La Jolla, CA; and mouse
EL-4) were cultured in RPMI 1640 medium containing 10% FCS,
glutamine, and antibiotics.
Special immunological reagents. Preparation and characterization
of monospecific rabbit antibody to mouse heat-shock protein hsp90
were described previously (3). Q5/13, a DR ,-chain framework mono-
clonal antibody, and Ql/28, a HLA class I framework monoclonal
antibody (both active in Western blotting) were gifts of Dr. Leslie
Walker, Scripps Clinic and Research Foundation. Horseradish-conju-
gated goat antibodies to human IgG and IgM (Cappel Laboratories,
Cochranville, PA) and rabbit IgG (Bio-Rad Laboratories, Richmond,
CA) were used in Western blotting experiments. Heat-aggregated IgG
was prepared from Cohn fraction II (Sigma Chemical Co., St. Louis,
MO) according to the technique of Dickler (13).
Preparation of T cell detergent lysates and purified plasma mem-
branes. This was performed as described in detail previously (14).
Briefly, cells were incubated in lysis buffer (PBS, pH 7.4 containing
0.5% Nonidet P-40, 2 mM phenylmethyl-sulfonyl fluoride, and 1
trypsin inhibitory unit/ml aprotinin) for 60 min on ice, followed by
clearance of the lysates of nuclei (monitored by phase contrast micros-
copy) by centrifugation at 400 g, and ultracentrifugation at 100,000 g
to remove cytoskeletal components and unsolubilized membranes.
Aliquots were kept frozen at -70°C until use. Highly purified plasma
membranes were isolated on discontinuous sucrose density gradients
from lymphoblastoid cells disrupted with a cell disrupter (Stansted
Fluid Power, Ltd., Essex, UK) according to the method ofCrumpton
and Snary (15). HLA class I and/or class II antigens, detected by
Western blotting with Q1/28 and Q5/13 monoclonal antibodies, re-
spectively, were enriched > 32-fold in purified membrane prepara-
tions relative to whole T cell lysates. Protein concentrations ofwhole T
cell lysates and purified membrane preparations were determined by a
modified Lowry procedure using appropriate blanks (16).
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SDS-PAGE and Western blotting. Cell detergent lysates or mem-
brane preparations were electrophoresed on 7.5% polyacrylamide slab
gels under reducing or nonreducing conditions according to the tech-
nique of Laemmli (17). Proteins were electroeluted from the gels to
nitrocellulose sheets for Western blot analysis (18), as described in
detail previously (14). The nitrocellulose sheets were cut into 5-mm
strips and incubated for 1-2 h at 250C in quenching buffer (20 mM
Tris-HCI, pH 7.4, 0.13 M NaCl, containing 5% nonfat dry milk),
followed by a 1-h incubation at 4VC with constant agitation in various
dilutions of SLE patient serum or rabbit anti-hsp90. A standard 1:20
dilution ofserum normalized to an IgG concentration of 10 mg/ml in
Tris-buffered saline (TBS), pH 7.4, provided optimum sensitivity and
minimum non-specific staining. Normal human serum, aggregated
normal IgG, and normal rabbit serum were used as controls. After
washing three times with TBS buffer containing 0.02% Tween 20,
strips were incubated for 1 h with appropriate peroxidase-conjugated
antiimmunoglobulin reagents, rewashed, and developed for color with
HRP color development reagent (Bio-Rad Laboratories). Protein
standards (Bio-Rad) were used to calibrate molecular weights (19). For
some experiments, lymphocytes were intrinsically labeled with (35S]-
methionine (Amersham Corp., Arlington Heights, IL) in methionine-
free RPMI 1640/dialyzed FCS. Labeled proteins were analyzed by
fluorography of SDS-polyacrylamide gel slabs.
Preclearance experiments. 75 ul of rabbit anti-mouse hsp90 or
normal rabbit serum were incubated with 100 ,l of protein A-Sepha-
rose 4B (Pharmacia Fine Chemicals, Piscataway, NJ) for 4 h at 4VC to
prepare solid-phase antibody. The beads then were washed 3X with
PBS and continuously rotated with 60 Al of Jurkat cell lysate (protein
concentration = 1 mg/ml) at 4VC for 4 h. The supernatant was recov-
ered by centrifugation and used as substrate in SDS-PAGE and West-
ern blotting.
Results
7 of 15 sera from patients with SLE contained IgG that reacted
with a molecule ofMr 90,000 on Western blots prepared from
nonionic detergent lysates of resting or activated peripheral T
cells electrophoresed on SDS-polyacrylamide gels under re-
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Figure 1. A 90-kD molecule widely expressed on cells ofhuman and
murine origin reacts with SLE IgG and rabbit antibody to the heat-
shock protein, hsp90. Nonidet P 40 cell lysates or purified plasma
membranes were electrophoresed under reducing condition on 7.5%
SDS-polyacrylamide gels. Proteins were electroeluted to nitrocellu-
lose and examined for IgG antibody staining. In a, blots were incu-
bated with serum from two normal individuals (lanes 1 and 2) or
from SLE patient Ne (lanes 3-9); in b, blots were incubated with rab-
bit antibody to hsp90 (lanes 1-8). Antigen substrates in a included:
also was detected in sera from 2/6 patients with polymyositis,
but not in sera from patients with rheumatoid arthritis (n = 10)
or systemic sclerosis (n = 7). The 90-kD target was expressed
by T cell lines ofvarying degrees ofmaturity and activation, by
B cells, and by a mouse T cell line, EL-4 (Fig. 1 a). Staining
appeared to involve specific antibody interactions since nor-
mal human sera and heat-aggregated IgG in concentrations
approximately twofold higher than that of SLE serum were
consistently negative in this regard (data not shown).
Three lines of evidence established that the 90-kD SLE
autoantibody target was the heat-shock protein, hsp90. First,
both proteins migrated together during SDS-PAGE (Figs. 1 a
and b). Second, when rabbit anti-hsp90 was used to preclear
lymphocyte detergent lysates, hsp90 and the SLE IgG-reactive
band were eliminated in parallel (Fig. 2, lanes 4 and 6, respec-
tively). Specificity of anti-hsp90 immunoabsorption in these
experiments was confirmed by the failure of control immuno-
precipitation with normal rabbit serum to remove this protein
(odd-numbered lanes in Fig. 2), by the specific absorption by
anti-hsp90 only of a 90,000-D protein in amido black stained
gels (Fig. 2, lane 2), and by the persistence in the anti-hsp90
precleared lysate of unrelated 57,000- and 34,000-D SLE anti-
body targets (Fig. 2, lane 6). Third, the 90-kD protein exhib-
ited the heat response characteristic of heat-shock proteins
(Fig. 3). HSB-2 and HUT 78 cells were incubated at 37°C or at
45°C, and labeled biosynthetically with [35S]methionine either
immediately, or after a 2-h incubation at 37°C following the
heat shock. Protein synthesis was decreased by the heat shock
in cells labeled immediately, but in cells labeled 2 h later,
uptake of [35S]methionine was increased in previously defined
(5) heat shock proteins ofMr 90,000, 110,000, and 72-73,000.
Discussion
This investigation delineates hsp90, a major intracellular
heat-shock protein, as a common IgG autoantibody target in
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PHA-activated human peripheral T cell detergent lysate (lanes 1-3),
HSB-2 lysate (lane 4), Jurkat lysate (lane 5), HUT 78 lysate (lane 6),
purified HUT 78 membranes (lane 7), mouse ELA4 lysate (lane 8),
and SB lysate (lane 9). Antigen substrates in b included: resting pe-
ripheral T cell lysate (lane 1), PHA-activated peripheral T cell lysate
(lane 2), HSB-2 lysate (lane 3), Jurkat lysate (lane 4), HUT 78 lysate
(lane S), purified HUT 78 membranes (lane 6), mouse EL-4 lysate
(lane 7), and SB lysate (lane 8).
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SLE. Autoantibodies against hsp90 were encountered in
< 10% of a panel of 23 sera from patients with non-SLE sys-
temic rheumatic diseases, and were not observed in normal
human sera. These data, albeit limited, raise the possibility
that anti-hsp90 autoantibodies may be relatively specific
for SLE.
In an earlier report from this laboratory (14), the 90 kD
protein now identified as hsp90 was thought to be a lympho-
cyte surface membrane target of antilymphocyte autoantibod-
ies in SLE because it was detected in purified plasma mem-
brane preparations. Copurification of hsp90 with plasma
membranes was confirmed in the present investigation, but by
immunofluorescence, this antigen clearly is intracytoplasmic,
with staining along the periphery of the cell adjacent to the
plasma membrane (3). Taken together, these observations
suggest that hsp90 is strongly linked to the inner surface ofthe
plasmalemma.
Heat-shock proteins are ubiquitous, highly conserved mol-
ecules that, by definition, exhibit increased synthesis following
exposure of cells to inductive stimuli that either denature pro-
teins or cause cells to accumulate abnormal proteins biosyn-
Figure 3. Heat shock re-
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lysates containing 7.5
ug protein in each lane were electrophoresed on a SDS polyacryl-
amide gel (7.5% reducing conditions) and the gel was autofluoro-
graphed.
thetically, e.g., supraphysiologic temperatures, certain drugs,
transition series metals, and various amino acid analogues (5).
In addition to a presumed physiologic role for heat-shock pro-
teins as a group in the general response of the cell to "stress,"
i.e., generation of thermotolerance, cell homeostasis, or ther-
moregulation, several recent observations suggest that hsp90
has important, if obscure, functions in the biology of the cell.
Thus, hsp90 has been shown to exist as a complex with steroid
receptors (8), and with several sarcoma virus-encoded trans-
forming peptides (6, 7), and binds to F-actin in a calmodulin
regulated, Ca2l-dependent manner (3, 4). Certain data suggest
that hsp90 and other heat-shock proteins also act in the transi-
tion of proliferating cells to Go or in maintaining cells in the
resting state (20). Whether autoantibodies to heat-shock pro-
teins contribute to the hormonal diathesis in SLE (21), to ab-
normal capping (22), or to endogenous lymphocyte activation
(23, 24) in this disorder is purely conjectural. Nonetheless, the
potential for in vivo relevance in this regard is provided by
data of Okudaira et al., who demonstrated that certain IgG
autoantibodies in SLE have the capacity to localize in the
cytoplasm of viable lymphocytes (25).
Also of importance are the clues that autoantibodies such
as anti-hsp90 offer with respect to putative microbial triggers
of autoimmunity. Indeed, an immunodominant peptide of
Schistosoma mansoni has amino acid sequence homology
with the heat-shock protein, hsp70, and may be responsible for
autoantibodies to hsp70 in individuals infected with this orga-
nism (10). A large body of additional evidence supports the
concept of molecular mimicry (epitope homology) as a basis
for the generation of autoantibodies following infection with
microbial "triggering agents" (reviewed in 9). For example,
- 4% of over 600 monoclonal antibodies generated against a
variety of DNA and RNA viruses cross-react with uninfected
host determinants (26). Autoantibodies developing in the
course of infectious mononucleosis are directed to epitopes
shared by multiple self antigens and the glycine-alanine repeat
region of Epstein Barr nuclear antigen- 1 (27). Analyses ofvirus
and host peptide sequences further supports a major role for
molecular mimicry in the generation of autoantibodies, e.g.,
the encephalitogenic site of myelin basic protein shows
marked homology with the nucleoprotein and hemagglutinin
of influenza virus, and with hepatitis B virus polymerase (9).
Thus, a potentially promising area for future investigation will
be the comparison of the amino acid sequence of hsp90 with
that of viral proteins. If homologous sequences are found, this
may lead to new insight into the etiology of SLE and related
autoimmune diseases.
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